Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
2
×
san francisco top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
biontech
biotech
blueprint medicineas
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
commissioner
crispr
crispr therapeutics
curevac
cybersecurity
deals
democrats
What
bio
2
×
cancer
2
×
new
2
×
allogene
bets
comes
companies
crispr
cut
date
deal
diversity
effective
enticed
evidence
hasn’t
hot
immunotherapy
investors
ipo
juno
latest
medicines
messenger
million
molecules
mrna
multiple
nearly
pharmaceutical
primarily
promise
proven
remains
rna
roundup
sanofi
second
shares
snapped
Language
Current search:
bio
×
photo
×
" san francisco blog main "
×
new
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
